IIM
TYRA icon

INTECH Investment Management’s Tyra Biosciences TYRA Stock Holding History

INTECH Investment Management’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$243K Sell
6,345
-3,456
-35% -$112K ﹤0.01% 1662
2025
Q4 		$258K Sell
9,801
-1,601
-14% -$29.4K ﹤0.01% 1843
2025
Q3 		$160K Sell
11,402
-8,517
-43% -$97.1K ﹤0.01% 2142
2025
Q2 		$191K Buy
19,919
+6,322
+46% +$60.1K ﹤0.01% 2108
2025
Q1 		$126K Buy
+13,597
New +$176K ﹤0.01% 2250

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

INTECH Investment Management's TYRA Position: Q1 2026 in Review

INTECH Investment Management reduced its Tyra Biosciences (TYRA) stake by 35% in Q1 2026, selling an estimated $112K and leaving 6,345 shares worth $243K. The position accounts for ﹤0.01% of the portfolio, ranked #1662.

INTECH Investment Management first reported a position in TYRA in Q1 2025 and has held it in 5 quarters since. The position peaked at $258K in Q4 2025. 164 funds tracked by Wall St. Rank hold TYRA as of Q1 2026.

  • INTECH Investment Management held 6,345 shares of Tyra Biosciences worth $243K as of Q1 2026.
  • INTECH Investment Management sold 3,456 Tyra Biosciences shares in Q1 2026, an estimated $112K.
  • Tyra Biosciences made up ﹤0.01% of INTECH Investment Management's portfolio in Q1 2026, its #1662 holding.
  • INTECH Investment Management first reported a position in Tyra Biosciences in Q1 2025 and has held it in 5 quarters since.
  • INTECH Investment Management's Tyra Biosciences position peaked at $258K in Q4 2025.
  • 164 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2026.

Based on INTECH Investment Management's 13F filing for Q1 2026, filed 8 May 2026.